European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- Jun 2026

Would you like a side-by-side comparison with the USP or JP tablet monographs as well?

Its specific requirements for tablet categories, mechanical strength, and, most notably, the precise and challenging subdivision rules for scored tablets, ensure patient safety. Through ongoing revisions and international harmonization efforts, monograph 0478 continues to set the gold standard for tablet quality, promoting public health and facilitating the global availability of safe, effective medicines. For any professional involved in pharmaceutical development, manufacturing, or quality assurance, a thorough understanding of this monograph is not optional—it is essential.

This blog post provides an overview of the , which serves as the legally binding standard for tablets marketed in signatory states.

The legal status of the Ph. Eur. is defined by the Convention on the Elaboration of a European Pharmacopoeia (1964). In EU law, any medicine seeking a Marketing Authorization (via the centralized, decentralized, or national procedure) must comply with the relevant Ph. Eur. monographs. Thus, Monograph 0478 is not a guideline but a . A batch of tablets failing the dissolution or uniformity test is considered adulterated and cannot be released to the market. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

Monograph 0478 applies specifically to . These are obtained by compressing uniform volumes of particles or particle aggregates generated through granulation methods. Exclusions and Boundaries

Manufacturers must adhere to specific "Production" and "Test" sections to satisfy regulatory bodies like the European Directorate for the Quality of Medicines & HealthCare (EDQM) . 1. Disintegration Testing (General Chapter 2.9.1)

: Single-layer or multi-layer structures resulting from a single compression of particles. No subsequent coating is applied. Would you like a side-by-side comparison with the

Uncoated tablets must typically disintegrate in water within . Film-coated tablets are allowed up to 30 minutes .

Monograph 0478 mandates several critical tests to ensure batch-to-batch consistency:

The monograph distinguishes several categories of tablets based on their intended use or design. A summary of these categories, their definitions, and key considerations is provided in the table below: Dissolution (2.9.3) Must produce a smooth

: Mandatory for tablets where the API comprises less than 2 mg or less than 2% of the total tablet mass. 4. Subdivision of Scored Tablets

: Including prolonged-release and delayed-release (gastro-resistant) forms to control where or when the drug is absorbed. Reference Standards

Mandatory for tablets with low doses of API (e.g., less than 25 mg or less than 25% of the total mass), requiring individual chemical assays of a specified number of tablets. B. Dissolution (2.9.3)

Must produce a smooth, uniform suspension that passes through a 710 µm sieve after disintegration. 5. Storage, Packaging, and Labeling

Before a tablet ever reaches a patient, it must survive manufacturing, bottling, shipping, and handling. This is where the physical attributes described in 0478 come into play.